Tamiflu Consumer Information - Article oseltamivir phosphate; Tamiflu
Article: Tamiflu Consumer Information
What is Tamiflu used for?
Tamiflu is for treating adults, adolescents, and pediatric patients 1year of age and older with the flu whose flu symptoms started within the last day or two. Tamiflu is also used to reduce the chance of getting the flu in people age 13 and older who have a higher chance of getting the flu because they spend time with someone who has the flu. Tamiflu can also reduce the chance of getting the flu if there is a flu outbreak in the community.
Special Warnings Concerning Tamiflu:
General Precautions with Tamiflu:
- Tamiflu has not been shown to treat flu-like illnesses caused by any virus other than influenza A and B (e.g., stomach flu, common cold, or other respiratory illnesses not caused by influenza).
- Other kinds of infections can appear like influenza or occur along with influenza, and need different types of treatment. Contact your health care provider if you feel worse or develop new symptoms during or after treatment, or if your influenza symptoms do not start to get better.
- Taking Tamiflu should not affect your decision to have an annual influenza vaccination.
- The safety and efficacy of repeated courses of treatment have not been established.
- Tamiflu is not indicated for treatment or prevention of the flu in patients less than 1 year of age.
What should I tell my doctor or health care provider?
Tell your doctor or health care provider if you:
- are taking any other medications
- have any type of kidney disease
- are trying to become pregnant, are already pregnant, or are breast-feeding
What are some possible side effects of Tamiflu?
(This is not a complete list of side effects reported with Tamiflu. Your health care provider can discuss with you a more complete list of side effects.)
- stomach pain
For more detailed information about Tamiflu, ask your health care provider.
Revised: 11/21/00, 5/26/04, 12/29/04ghc
|Active Ingredient:||oseltamivir phosphate|
|Strength(s):||75mg and 12mg/mL|
|Dosage Form(s):||Capsule and Powder for Oral Suspension|
|Company Name:||Roche Laboratories, Inc.|
|*Date Approved by FDA:||October 27, 1999|
|*Approval by FDA does not mean that the drug is available to consumers at this time.|
Source: U.S. Food and Drug Administration
Cache Date: February 24, 2005